You are on page 1of 4

07-09-2022

Currently different countries have to follow different regulatory requirements for


approval of new drug.
For Marketing Authorization Application (MAA) : a single regulatory approach is
applicable to various countries is almost a difficult task. Therefore, it is necessary to
have knowledge about regulatory requirement for MAA of each country. Each country
Regulatory requirements for drug has its own regulatory requirements which have to be satisfied to approve a new drug
in that particular country.
approval:
Drug Development Teams

Regulation of Drug Approval Process

DRUG DESCOVERY AND DEVELOPMENT


Approval of New Drug in India :
If any company in India wants to manufacture or import a new
drug, apply to seek permission from the licensing authority
(DCGI) by filing in Form 44 also submitting the data as given
in Schedule Y of Drugs and Cosmetics Act 1940 and Rules
1945.

 To prove its efficacy and safety in Indian population they


need to conduct clinical trials in accordance with the
guidelines specified in Schedule Y and submit the report of
such clinical trials in specified format.

 The regulations under Drugs and Cosmetics Act 1940 and


its rules 1945, 122A, 122B and 122D describe the
information required for approval of an application to
import or manufacture of new drug for marketing.

Drug Development Teams & Their Responsibilities


Some of the rules & guidelines that should be followed
The drug development team includes a diverse group of individuals with different
for regulation of drugs in India are: philosophies and approaches to the development process. All team members must work
closely together to ensure that a drug is both safe and efficacious.
 Drugs and Cosmetics Act 1940 and its rules 1945
The responsibilities of these project teams include –
 Narcotic Drugs and Psychotropic Substances -1985 1. Reviewing research results from experiments conducted by any of the various
scientific disciplines.
 Drugs Price Control Order 1995 2. Integrating new research results with previously generated data.
3. Planning research studies to further characterize a drug candidate.
 Consumer Protection Act-1986 4. Preparing a detailed drug development plan, including designation of key points or
development milestones, generating a timeline for completion, and defining the
 Factories Act-1948 critical path.
5. Monitoring the status of research studies to ensure that they are being conducted
 Law of Contracts (Indian contract Act-1872) according to the timeline and critical path in the development plan and, if appropriate,
modifying the plan as new information becomes available.
 Monopolistic & Restrictive Trade Practices Act-1969 6. Comparing research results and development status and timelines with drug
candidates under development by competitors.
 ICH GCP Guidelines 7. Conducting appropriate market surveys to ensure that the development of a drug
candidate is economically justified and continues to meet a medical need.

1
07-09-2022

2
07-09-2022

3
07-09-2022

You might also like